Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

neurological · Mechanism Report

Can mixed exposure to gliotoxin, mycophenolic acid, citrinin, fumonisin B1, and nivalenol cause neurological stress?

Mixed exposure to these compounds is mechanistically plausible as a source of neurological stress, but it has not been shown to cause neurological harm in people.

PlausibleOctober 21, 20266 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Gliotoxin, mycophenolic acid, citrinin, fumonisin B1, and nivalenol can increase oxidative stress, disrupt mitochondrial function, and alter immune signaling, creating plausible neurological stress when exposure is mixed.

laying out figure…
0 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says this mixture could increase oxidative stress, disrupt mitochondrial function, and alter immune signaling, creating a biologically coherent route to neurological stress. The mechanism framing emphasizes overlapping redox, mitochondrial, and immune effects from several of the compounds, especially fumonisin B1, gliotoxin, citrinin, and nivalenol-related pathways. Even so, the conclusion remains that human neurological harm from this specific mixed exposure has not been demonstrated.

Verified conclusion

The proposed mixed exposure has a biologically coherent toxicologic rationale, but it has not been demonstrated to cause neurological harm in people.

Mechanistic evidence

  • Oxidative and mitochondrial effects: Gliotoxin, citrinin, and fumonisin B1 have experimental evidence for reactive-oxygen-species generation or oxidative-stress signaling. Citrinin, fumonisin B1, and trichothecene-related effects relevant to nivalenol can affect mitochondrial membrane integrity, respiration, or inhibitory pathways. Fumonisin B1, in particular, has been reported to inhibit mitochondrial complex I, reduce respiration, depolarize mitochondria, and increase ROS.
  • Immune signaling: Gliotoxin can modify phagocyte and cytokine responses; citrinin has cytokine-related effects; and fumonisin B1 and nivalenol/trichothecene-related exposures can alter inflammatory cytokine and chemokine signaling. Concurrent exposures could therefore affect overlapping redox–mitochondrial–immune pathways.

Neurological relevance

  • Plausible, not established: Neurons are sensitive to impaired bioenergetics, oxidative injury, and inflammatory signaling. Fumonisin B1 has experimental neuronal toxicity, and gliotoxin’s redox and immune effects are neurologically relevant mechanisms. These findings support potential cellular neurological stress, rather than evidence of cognitive impairment, neurodegenerative disease, or other clinical neurological outcomes.
  • No direct neuronal study has tested the specified five-agent combination, including the more limited fumonisin B1–nivalenol combination.

Interpretation for real-world exposure

  • The critical uncertainty is mixture behavior: no studies establish whether these five agents act additively, synergistically, or antagonistically at human-relevant concentrations or exposure ratios.
  • Mycophenolic acid’s contribution to the proposed shared oxidative, mitochondrial, and immune profile is particularly uncertain.

Bottom line

  • Mixed exposure is mechanistically plausible as a source of oxidative stress, mitochondrial disturbance, and immune modulation; neurological stress remains a low-confidence extrapolation, not a proven human health effect.

References

  1. Fungal Toxins and Host Immune Responses — frontiersin.org ↗
  2. Mycotoxins' Toxicological Mechanisms Involving Humans, Livestock ... — pmc.ncbi.nlm.nih.gov ↗
  3. [PDF] Toxicological interactions between mycotoxins - HAL — hal.science ↗
  4. Fumonisin B1-induced mitochondrial toxicity and ... — digitalknowledge.cput.ac.za ↗
  5. Cell Type-Specific Effects of Fusarium Mycotoxins on Primary ... — pmc.ncbi.nlm.nih.gov ↗
  6. Fumonisin B1 neurotoxicity: Preclinical evidence, biochemical ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible19 sourcesCan chronic low-level lead and inorganic arsenic exposure affect neurological health even below laboratory thresholds?→Plausible7 sourcesAre antibodies to neuronal surface proteins directly pathogenic?→